Diagnoses of Multiple Sclerosis and Related Disorders and Disease‐Modifying Therapies: A Comparison of the Danish Multiple Sclerosis Registry With Other Danish Health Registries

Documenti analoghi

• De‐Escalation of Disease‐Modifying Therapy in Multiple Sclerosis—A Danish Nationwide Cohort Study
  di: Frederik Elberling, et al.
  Pubblicazione: (2025)
• Exploring Different Levels of Contact Frequency in Multiple Sclerosis Care
  di: Sofia Persson, et al.
  Pubblicazione: (2025)
• Cognitive Outcomes in Myelin Oligodendrocyte Glycoprotein‐IgG Associated Disease Compared to Multiple Sclerosis
  di: Eileen Galvani, et al.
  Pubblicazione: (2025)
• Predictors of Radiological and Clinical Disease Reactivation in Multiple Sclerosis Patients After Cessation of Natalizumab (Tysabri)
  di: Roba El Zibaoui, et al.
  Pubblicazione: (2025)
• The Role of Sex and Other Personal Characteristics in the Effects of Symptoms Severity on Self‐Care Agency in Individuals with Multiple Sclerosis
  di: Pınar Yeşil Demirci, et al.
  Pubblicazione: (2024)